Skip to main content
PRFX
NASDAQ Life Sciences

PRF Technologies Finalizes Highly Dilutive $10M Equity Line with YA II PN, LTD., Registering 345% of Outstanding Shares for Resale

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.51
Mkt Cap
$1.275M
52W Low
$1.41
52W High
$17.95
52W Position info
7.1% above low
Off High info
92% below high
Rel. Volume
Market data snapshot near publication time

PRFX is trading near its 52-week low of $1.41 (7.1% above the low).

Summary

PRF Technologies has finalized a highly dilutive equity line agreement to raise up to $10.0 million, registering 3,000,000 shares for resale by YA II PN, LTD., representing 345% of current outstanding shares.


Key Events · Financing and Capital Events · PRFX

  • Equity Line Agreement Finalized

    This 424B3 prospectus supplement finalizes the terms of the Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD., previously announced on May 7, 2026, and registered via an F-1 on May 13, 2026. The company may sell up to $10.0 million in ordinary shares to YA over 36 months.

  • Massive Potential Dilution

    The filing registers 3,000,000 ordinary shares for resale by YA, including 2,975,616 'Advance Shares' that the company may sell to YA. This represents approximately 345% of the 868,756 ordinary shares outstanding as of May 12, 2026, indicating extreme potential dilution for existing shareholders.

  • Discounted Share Sales

    Shares sold to YA under the agreement will be priced at 97% of the lowest of the three daily volume-weighted average prices (VWAPs) during a pricing period, reflecting a significant discount to market prices.

  • Capital for Operations

    Proceeds from the company's sales to YA will be used for research and development costs, working capital, and general corporate purposes, providing a critical funding source for the micro-cap company.


Analysis · PRFX · Life Sciences

This prospectus supplement finalizes the terms for a Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD., allowing PRF Technologies to sell up to $10.0 million in ordinary shares to YA over 36 months. The filing registers 3,000,000 shares for resale by YA, which represents approximately 345% of the company's current outstanding shares. This level of potential dilution is extremely significant for existing shareholders, especially given the company's micro-cap status. Shares sold to YA will be at a discount (97% of the lowest VWAP), indicating a high cost of capital. While the agreement provides a crucial funding source for R&D and working capital, the terms are highly dilutive and will likely exert substantial downward pressure on the stock price.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PRFX was trading at $1.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3M. The 52-week trading range was $1.41 to $17.95. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRFX - Latest Insights

PRFX
Nov 13, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7834
Real-time Price: $0.740 info
Change: -$0.0434 (-6%) info
Market Cap: $2.381M info
PRFX
Nov 12, 2026, 4:31 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.7354
Real-time Price: $0.740 info
Change: +$0.0046 (+0.63%) info
Market Cap: $2.381M info
PRFX
Nov 12, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.786
Real-time Price: $0.740 info
Change: -$0.046 (-6%) info
Market Cap: $2.381M info
PRFX
Nov 05, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7588
Real-time Price: $0.740 info
Change: -$0.0188 (-2%) info
Market Cap: $2.381M info
PRFX
Nov 03, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7705
Real-time Price: $0.740 info
Change: -$0.0305 (-4%) info
Market Cap: $2.381M info